Gene editing treatment strategies for retinitis pigmentosa assessed in Xenopus laevis carrying a mutant Rhodopsin allele
Journal of Translational Genetics and Genomics · 2022 · 6 · 111-125
DOI: 10.20517/jtgg.2021.49 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Translational Genetics and Genomics, 2022. Verfasst von Farhad Ghaseminejad und 4 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Gefördert von: Canadian Institutes of Health Research, National Science and Engineering Research Council.
Abstract (Originalsprache)
Aim
To examine the utility of gene editing therapies for retinitis pigmentosa using Xenopus laevis carrying a mutation in Rhodopsin.
Methods
Xenopus laevis were genetically modified using CRISPR-Cas9 based methods and characterized by Sanger sequencing, dot blot, electroretinography, and confocal microscopy.
Results
We identified genetically modified Xenopus laevis carrying a net 12 base pair deletion in the Rho.L gene. These animals have a retinal degeneration that is apparent by 14 days, with abnormal or missing rod outer segments, and a reduced electroretinogram signal. We prevented the majority of this retinal degeneration via a treatment strategy using a single sgRNA to neutralize the mutant allele via non-homologous end joining, yielding long-term improvements in histology and the electroretinogram. A second strategy using two sgRNAs to generate large deletions in the mutant allele was also successful, but did not significantly improve outcomes relative to the single-guide strategy as it was less efficient. We found limited evidence of success with a third strategy dependent on homology-directed repair; this treatment was also too inefficient to generate an outcome superior to the single-guide strategy.
Conclusion
Our results demonstrate the utility of this new Xenopus laevis model for rapidly assessing and comparing multiple gene-editing based treatment strategies. We conclude that it would be technically difficult to improve on the simple single-guide based strategy, as strategies requiring multiple successive events (such as cleavage followed by homology-directed repair) are likely to be less efficient.
Förderung
- Canadian Institutes of Health Research
- National Science and Engineering Research Council
Zitieren
APA
Ghaseminejad, F., Tam, B. M., Chiu, C. N., Feehan, J. M., & Moritz, O. L. (2022). Gene editing treatment strategies for retinitis pigmentosa assessed in Xenopus laevis carrying a mutant Rhodopsin allele. Journal of Translational Genetics and Genomics, 6, 111-125. https://doi.org/10.20517/jtgg.2021.49
Vancouver
Ghaseminejad F, Tam BM, Chiu CN, Feehan JM, Moritz OL. Gene editing treatment strategies for retinitis pigmentosa assessed in Xenopus laevis carrying a mutant Rhodopsin allele. Journal of Translational Genetics and Genomics. 2022;6:111-125. doi:10.20517/jtgg.2021.49
BibTeX
@article{Ghaseminejad2022,
author = {Ghaseminejad, Farhad and Tam, Beatrice M. and Chiu, Colette N. and Feehan, Joanna M. and Moritz, Orson L.},
title = {Gene editing treatment strategies for retinitis pigmentosa assessed in Xenopus laevis carrying a mutant Rhodopsin allele},
journal = {Journal of Translational Genetics and Genomics},
year = {2022},
volume = {6},
pages = {111--125},
doi = {10.20517/jtgg.2021.49}
}
EUVIMED